Datar Cancer Genetics Unveils Exacta AI: A Revolutionary AI-Driven Cancer Treatment Platform

Metropolis Healthcare Partners with Roche to Launch Self-Sampling HPV DNA Test for Cervical Cancer Screening in India

Union Budget 2025: Full Exemption from Basic Customs Duty (BCD) for 36 Lifesaving Drugs

Dr. Jitendra Singh Inaugurates Centre for Advanced Genomics & Precision Medicine at AIIMS Jammu

Union Budget 2025-26: Key Healthcare Measures for Cancer Care and Access to Life-Saving Drugs

FDA Approves Roche’s PATHWAY HER2 Test for Identifying HER2-Ultralow Breast Cancer Patients Eligible for ENHERTU

Bristol Myers Squibb’s Breyanzi® Receives CHMP Recommendation for Relapsed or Refractory Follicular Lymphoma in the EU

NHS to Offer Groundbreaking Gene Therapy for Sickle Cell Disease

Quibim Secures $50M Series A to Advance AI-Powered Imaging for Precision Medicine

Apollo Hospitals Unveils Advanced Oncology Facility in Chennai

Beckman Coulter’s Alzheimer’s Blood Test Receives FDA Breakthrough Device Designation

ANGLE Announces Breakthrough Dual CTC-DNA and ctDNA Analysis with Illumina’s NGS Solution

Diatech Pharmacogenetics and Merck Expand Collaboration to Enhance RAS Biomarker Testing in MEA Region

DCG Unveils AI-Powered Video-Reporting for Personalized Chemotherapy Selection

FDA Approves Monthly Maintenance Dosing for LEQEMBI® in Alzheimer’s Treatment

Home
/
update
/
details

Vgenomics Raises Seed Capital to Propel Biotech Initiatives

NextEdge Admin

01 Jan 2024

1 min 18 sec

Vgenomics, a healthcare and biotech startup, has successfully raised an undisclosed amount in a seed funding round led by Mumbai Angels and O2 Angel Network. Notable participation came from well-known angels such as Rohit Chanana and Sabine Kapasi. The company, founded by Rahila Sarda, Preeti Gupta Lal, and a team of female scientists, plans to utilize the funds to expand its current operations and develop additional diagnostic solutions.

Specializing in diagnostic and therapeutic genome sequencing technologies for rare childhood diseases, Vgenomics serves clients including researchers and clinicians from esteemed institutions such as AIIMS, Dr. Shroff, and PGIMER. The startup envisions leveraging the raised capital to unite organizations dedicated to rare diseases and establish Vgenomics as the go-to hub for rare disease solutions, according to Sardar, the Co-founder and CEO of Vgenomics.